Metformina Aurobindo Italia

Metformin, the active ingredient in Metformina Aurobindo Italia, is a biguanide presented as an oral tablet for oral use. It is used to improve glycemic control in adults with type 2 diabetes mellitus. GNH USA supplies Metformina Aurobindo Italia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformina Aurobindo Italia belongs to the biguanide class and is indicated for conditions related to impaired glucose regulation.

Type 2 diabetes mellitus: improves blood glucose control and reduces HbA1c levels. Prediabetes (impaired glucose tolerance): helps delay progression to overt diabetes. Polycystic ovary syndrome (PCOS): may improve insulin resistance and menstrual regularity.

Metformina Aurobindo Italia may cause a range of adverse reactions.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or loss of appetite. - Diarrhea: frequent loose stools, especially during treatment initiation. - Metallic taste: transient alteration in taste perception.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening metabolic complication. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: abnormal liver enzymes or hepatitis. - Hypoglycemia: usually when combined with other glucose‑lowering agents. - Pancreatitis: inflammation of the pancreas.

Before prescribing Metformina Aurobindo Italia, clinicians should consider several safety factors.

Renal function: assess creatinine clearance and avoid use in severe renal impairment. Liver disease: evaluate hepatic status as dysfunction may increase risk of lactic acidosis. Cardiac failure: monitor patients with congestive heart failure for signs of hypoxia. Elderly patients: start at lower doses and titrate cautiously. Alcohol consumption: advise limiting intake to reduce lactic acidosis risk. Store at room temperature: keep in the original container, protect from moisture and heat.

Metformina Aurobindo Italia can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure. - Cimetidine: can increase metformin plasma concentrations. - Alcohol excess: raises risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Diuretics: can affect renal clearance of metformin. - ACE inhibitors or ARBs: monitor renal function and potassium levels. - NSAIDs: may impair renal function, increasing metformin exposure. - Corticosteroids: can raise blood glucose, requiring dose adjustments.